Identification of Arginine Deiminase Gene Therapy for Disordered Proteins
- Technology Benefits
- Decreases tau levels, Metabolizes arginine, Does not increase nitric oxide or polyamines
- Detailed Technology Description
- Our inventorΓÇÖs have successfully mammalianized, cloned, and expressed arginine deiminase (ADI) to deplete arginine without increasing either nitric oxide or polyamines. When overexpressed in the brain of tau transgenic mice, ADI significantly decreased tau pathology. Additionally, ADI reduced tau levels in cells that overexpress tau. This novel gene therapy by ADI may serve as a therapeutictarget in reducing aggregation prone proteins such as tau, thus leading to a promising new treatment for age-associated neurodegenerative diseases.
- *Abstract
-
Researchers at the University of South Florida have developed a novel gene therapy for the treatment of age-associated neurodegenerative diseases.
- Country/Region
- USA
For more information, please click Here
